Clinical Trials Logo

Filter by:
NCT ID: NCT02839551 Completed - Clinical trials for Drug Hypersensitivity

Optimal Doses for Drug Provocation Tests to Beta-lactams

NewBL
Start date: May 4, 2016
Phase: N/A
Study type: Interventional

Drug provocation tests (DPT) are widely in case of suspicion of drug hypersensitivity (and in the absence of contraindications), but there are no standardized protocols and most groups use hypothesis (clinically-driven) protocols. investigators used 20 year experience in drug hypersensitivity to analyse retrospectively 171 patients (accounting for 182 positive DPT to beta-lactams). Using survival analysis, they identified optimal doses to include in a data-driven protocol. This data-driven protocol will be applied to new prospective patients, to test its safety and benefits (gain in time, hospital and patient benefits).

NCT ID: NCT02839473 Completed - Breast Cancer Clinical Trials

Hydrosorb® Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial

HYDROSORB
Start date: March 2010
Phase: Phase 3
Study type: Interventional

The primary objective consisted of avoiding deterioration and/or restoring the integrity of the skin of patients treated by radiotherapy, right from the first signs of grade 1 or 2 radiation dermatitis.

NCT ID: NCT02839304 Completed - Atrial Fibrillation Clinical Trials

Investigation of the Adagio Cryoablation System in Patients With Atrial Fibrillation

CryoCure2
Start date: July 2016
Phase: N/A
Study type: Interventional

The objective of the study is to demonstrate the safety and feasibility of the Adagio Cryoablation System is subjects with Paroxysmal (PAF), Persistent (PsAF) and Long-Standing Persistent Atrial Fibrillation.

NCT ID: NCT02839187 Completed - Alzheimer Disease Clinical Trials

Neuro Imaging and Multimodal Alzheimer's Disease

NIMAD
Start date: June 2010
Phase: N/A
Study type: Interventional

The present study aimed at measuring cerebral changes in Alzheimer Disease (AD) patients, who responded to strict physiological criteria typical of AD pathology. The objective of the present study was to identify the earliest alterations in cerebral connections that could contribute to the initial episodic memory impairment.

NCT ID: NCT02838342 Completed - Clinical trials for Neuroendocrine Tumors

Pharmaco-immunological Study of Interferon-alpha and Metronomic Cyclophosphamide Association in Neuroendocrine Tumors

EPICentro
Start date: May 19, 2015
Phase: Phase 2
Study type: Interventional

This study will evaluate the potential immunomodulatory synergy of the association of metronomic cyclophosphamide (CMC) and interferon-alpha (IFN-alpha).

NCT ID: NCT02838251 Completed - Ulcer Clinical Trials

Effects of Compression in Mixed Ulcers

ULCEREMIXTE
Start date: September 2015
Phase: N/A
Study type: Observational

About 15% to 30% of patients with venous leg ulcers have a peripheral arterial disease (PAD) associated. The compression band is still a controversial issue in this context. It allows the reduction of venous hypertension and edema, but it could potentially degrade the arterial infusion of high levels of compression. The French High Authority for Health (HAS) defines mixed ulcers by IPS between 0.5 and 0.9. Investigators distinguish mixed ulcers blood predominance for IPS between 0.5 and 0.7; and mixed ulcers predominantly venous blood with moderate involvement for IPS values between 0.7 and 0.9. Several studies have shown that IPS> 0.8 allowed a high compression, between 30 and 40 mmHg. In the case of mixed ulcers with IPS between 0.6 and 0.8, the HAS recommends using a lighter compression, bit by elastic bands (exercising low power compression at rest) under medical supervision, informing the patient to remove the bandage if pain or aggravation. It is therefore necessary to adapt the compression therapy in case of venous ulcers associated with arterial disease by providing a lower compression 30 mmHg short stretch. For HAS, IPS <0.6 against indicates compression. A recent study showed that compression bit elastic bands could not only improve venous return, but it would also increase the distal arterial flow in a patient population with mixed ulcers. In this study, 25 patients had between IPS 0.5 and 0.8; or for certain patients below the threshold of 0.6 indicates that against a compression according to HAS. To our knowledge this is the only study that has examined the effect of compression on blood perfusion.

NCT ID: NCT02837965 Completed - Bullous Pemphigoid Clinical Trials

Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid

EDP-PB
Start date: September 26, 2013
Phase:
Study type: Observational

The study is an observational, multi-center, prospective, non-interventional and open-label data collection study assessing outcomes, treatment patterns, adverse events and costs in patients diagnosed with bullous pemphigoid. The patient enrollment period will be 1 year with a follow-up (observation period) of 1 year for each patient. Four dermatology centres in France will participate. The hypothesis to be answered by the study is that superpotent topical corticosteroid therapy is properly used to treat bullous pemphigoid in real-world life as recommended by French guidelines and whether this treatment influences the medical costs by comparison with systemic therapies (e.g. methotrexate or prednisone).

NCT ID: NCT02837926 Completed - Cervical Cancer Clinical Trials

Comparing Health Services Interventions for the Prevention of HPV-related Cancer

CoheaHr-WP4
Start date: May 2016
Phase: Phase 4
Study type: Interventional

The study aims to identify global and local determinants of HPV vaccine acceptability, HPV vaccine uptake and compliance as well as identify logistics and programmatic issues in each country to offer the HPV vaccine, as a potential cervical cancer prevention strategy, to mid-aged women attending screening.

NCT ID: NCT02837835 Completed - Pneumonia Clinical Trials

Lung Concentrations of Ceftazidime in Patients With Ventilator-associated Pneumonia

CEFTALC
Start date: March 2005
Phase: Phase 3
Study type: Interventional

Ceftazidime is a beta-lactam compound that exerts a time-dependent bactericidal effect. Numerous arguments are in favor of continuous administration of ceftazidime, both for reasons of clinical efficacy and to preserve bacteriological mutation. The investigators report a prospective, single-center, parallel-group, randomized, controlled trial comparing two modes of administration of ceftazidime, namely, continuous administration (loading dose of 20 mg/kg of body weight followed by 60 mg/kg/day) versus intermittent administration (20 mg/kg over 30 min every 8 h) in 34 patients with ventilator-associated pneumonia due to Gram-negative bacilli. The study was performed over 48 h with 13 and 18 assessments of serum ceftazidime in the continuous-infusion group (group A) and the intermittent-fusion group (group B), respectively. Bronchoalveolar lavage (BAL) was performed at steady state in both groups at 44 h to determine ceftazidime levels in the epithelial lining fluid. The investigators chose a predefined threshold of 20 mg/liter for serum concentrations of ceftazidime because of ecological conditions in our center.

NCT ID: NCT02837406 Completed - Clinical trials for Evaluation of a National Health Information Technology-based Program to Improve Healthcare Coordination and Access to Information

Evaluation of the Health Digital Territories Program in the Five Pilot Territories (EvaTSN Project )

EvaTSN
Start date: May 20, 2015
Phase:
Study type: Observational

The aim is to evaluate a national health information technology-based program to improve healthcare coordination and access to information.